Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children

Pediatric Infectious Disease Journal

Volumn 22, Issue 5, 2003, Pages 405-412

  Piglansky, Lolita ^a   Leibovitz, Eugene ^a   Raiz, Simon ^a   Greenberg, David ^a   Press, Joseph ^a   Leiberman, Alberto ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Amoxicillin; Bacteriologic failure; Haemophilus influenzae; Relapse; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFUROXIME AXETIL; PENICILLIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTITIS MEDIA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 0038586380     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000065688.21336.fa     Document Type: Article

References (30)

1. Kaleida PH, Casselbrandt ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991;87:466-74.
2. Krause PJ, Owens NJ, Nightinghale CH, Klimek JJ, Lehmann WB, Quintiliani R. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis 1982;145:S15-21.
3. Nelson CT, Maon EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear fluid and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
4. Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink SG. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J 1998;17:149-56.
5. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in era of pneumococcal resistance - a report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Pediatr Infect Dis J 1999;18:1-9.
6. Lister PD, Pong A, Chartrand SA, Sanders CC. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci. Antimicrob Agents Chemother 1997;41:1926-32.
7. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15:255-9.
8. Blumer JL. Implications of pharmacokinetics in making choices for the management of acute otitis media. Pediatr Infect Dis J 1998;17:565-70.
9. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1997;16:710-11.
10. Howie VM. Eradication of bacterial pathogens from middle ear infections. Clin Infect Diseases 1992;14(Suppl 2):209-10.
11. Dagan R, Fliss DM, Leibovitz E, et al. Antibiotic treatment in acute otitis media: "in vivo" demonstration of antibacterial activity. Clin Microbiol Infect 1997;3(Suppl 3):43-68.
12. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9.
13. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J 1998;17:126-31.
14. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriological efficacy of oral azithromycin and oral cefaclor in the treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000;44:43-50.
15. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriological and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 2001;20:260-4.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 10th informational supplement (aerobic dilution). vol 20, no 2. Document M7-A5 (Suppl M100-S10). Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
17. Dagan R, Piglansky L, Yagupsky P, Fliss DM, Leiberman A, Leibovitz E. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor and amoxicillin [Abstract K-103]. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997:346.
18. Dagan R, Hoberman A, Johnson C, et al. Bacteriological and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001;20:829-37.
19. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon." J Pediatr 1992;120:72-7.
20. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1998;17:463-9.
21. McCormick DP, Lim-Melia E, Saeed K, Baldwin CD, Chonmaitree T. Otitis media: can clinical findings predict bacterial or viral etiology? Pediatr Infect Dis J 2000;19:256-8.
22. Musher D, Dagan R. Is the pneumococcus the one and only in acute otitis media? Pediatr Infect Dis J 2000;19:399-400.
23. Cohen R, De La Rocque F, Boucherat M, Doit C, Bingen E, Geslin P. Treatment failure in otitis media: an analysis. J Chemother 1994;6(Suppl 4):17-22.
24. Leibovitz E, Raiz S, Piglansky L et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J 1998;17:463-9.
25. Del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998;17:94-7.
26. Gehanno P, N'Guyen L, Derriennic M, Pichon F, Goehrs JM, Berche P. Pathogens isolated during treatment failures in otitis. Pediatr Infect Dis J 1998;17:885-90.
27. Brook I, Yocum P. Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Pediatr Infect Dis J 1995;14:805-8.
28. Block SL, Hedrick JA, Tyler RD, Smith RA, Harrison CJ. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr Infect Dis J 2001;20:1017-21.
29. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J 2000;19(Suppl):S57-65.
30. Leibovitz E, Piglansky L, Raiz S, et al. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone in the treatment of non-responsive acute otitis media. Pediatr Infect Dis J 2000;19:1040-5.